The complex interplay between inflammation, the microbiota and colorectal cancer
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The microbiome has captured the attention of scientists from multiple research fields including ecology, immunology, microbiology and cancer biology. The microbial community living in the gastrointestinal tract is the most abundant and diverse niche of the human body and it is not surprising that microbiome research has predominantly focused upon this organ system. In this addendum, we summarize the latest developments in microbiome research on inflammatory bowel diseases and colorectal cancer. In addition, we highlight our recent findings that chronic intestinal inflammation modulates microbial community composition and the development of colorectal cancer. Our findings redefine the paradigm of inflammation-associated cancer by illuminating the key role of bacteria in development of colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713
Commensal Host-Bacterial Relationships in the Gut
Hooper, L. V., & Gordon, J. I. (2001) · Science · doi:10.1126/science.1058709 · Cited by 2,362
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327
Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Fölsch, U. R., Timmis, K. N., & Schreiber, S. (2004) · Gut · doi:10.1136/gut.2003.025403 · Cited by 1,311
Research works printed but not linked: 23
- Heidland A, 2006, J Nephrol, 19, S102
- 10.1053/j.gastro.2012.07.009 · DOI · Paper page
- 10.1016/S0140-6736(00)04046-0 · DOI · Paper page
- 10.1053/j.gastro.2011.01.057 · DOI · Paper page
- 10.1002/ibd.20392 · DOI · Paper page
- 10.1001/jama.274.13.1064 · doi:10.1001/jama.274.13.1064 · Paper page
- 10.1038/nrg3129 · DOI · Paper page
- 10.1371/journal.pone.0016393 · DOI · Paper page
- 10.1038/ismej.2012.43 · DOI · Paper page
- 10.1371/journal.pone.0039743 · DOI · Paper page
- 10.1002/ibd.21606 · DOI · Paper page
- 10.1053/j.gastro.2004.03.054 · DOI · Paper page
- 10.1016/S0016-5085(98)70019-8 · DOI · Paper page
- 10.1016/S0016-5085(98)70194-5 · DOI · Paper page
- 10.1016/S1286-4579(01)01387-9 · DOI · Paper page
- 10.1053/j.gastro.2005.02.009 · DOI · Paper page
- 10.1073/pnas.1001261107 · DOI · Paper page
- 10.1111/j.1574-6968.2007.00889.x · DOI · Paper page
- 10.1128/IAI.00522-09 · DOI · Paper page
- 10.4161/gmic.21737 · DOI · Paper page
- 10.1002/ibd.21354 · DOI · Paper page
- 10.1016/S1471-4914(01)02194-3 · DOI · Paper page
- 10.1016/j.jmb.2012.09.017 · DOI
Cited by
Schwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689
Self-citationGut microbiota imbalance and colorectal cancer
Gagnière, J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.501 · Cited by 845
The Gut Microbiome Modulates Colon Tumorigenesis
Zackular, J. P., Baxter, N. T., Iverson, K. D., Sadler, W. D., Petrosino, J. F., Chen, G. Y., & Schloss, P. D. (2013) · mBio · doi:10.1128/mbio.00692-13 · Cited by 629
Beauchemin, N., & Arabzadeh, A. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9444-6 · Cited by 538
Milk kefir : nutritional, microbiological and health benefits
Rosa, D. D., Dias, M. M. S., Grześkowiak, Ł. M., Reis, S. A., Conceição, L. L., & Peluzio, M. D. C. G. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422416000275 · Cited by 463
Chronic ulcerative colitis and colorectal cancer
Rogler, G. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.07.032 · Cited by 413
Arthur, J. C., Gharaibeh, R. Z., Mühlbauer, M., Perez-Chanona, E., Uronis, J. M., McCafferty, J., Fodor, A. A., & Jobin, C. (2014) · Nature Communications · doi:10.1038/ncomms5724 · Cited by 392
Self-citationDysbiosis of gut microbiota in promoting the development of colorectal cancer
Zou, S., Fang, L., & Lee, M.-H. (2018) · Gastroenterology Report · doi:10.1093/gastro/gox031 · Cited by 280
Dietary Emulsifier–Induced Low-Grade Inflammation Promotes Colon Carcinogenesis
Viennois, E., Merlin, D., Gewirtz, A. T., & Chassaing, B. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1359 · Cited by 268
Fusobacterium nucleatum and colorectal cancer: A review
Shang, F.-M., & Liu, H.-L. (2018) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v10.i3.71 · Cited by 258
The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention
McFadden, R.-M. T., Larmonier, C. B., Shehab, K. W., Midura-Kiela, M., Ramalingam, R., Harrison, C. A., Besselsen, D. G., Chase, J. H., Caporaso, J. G., Jobin, C., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000522 · Cited by 225
“, a symbiont that is able to promote pathology only when host’s specific genetic or environmental conditions are altered.(11) Currently, 3 theories are proposed to explain the microbial influence on colon cancer development: a model in which the pathogenesis is driven by selected pathobiont(s); a model in”
BackgroundSelf-citationHintze, K. J., Cox, J. E., Rompato, G., Benninghoff, A. D., Ward, R. E., Broadbent, J., & Lefevre, M. (2014) · Gut Microbes · doi:10.4161/gmic.28403 · Cited by 135
“Gut microbiota are now recognized as key factors in the etiology of several important human diseases, including obesity,(3,4) metabolic syndrome,(5,6) inflammation,(5,7) and colorectal cancer.(8,9) The field of gut microbiology and associated health outcomes has advanced greatly through the use of “humanized” mouse mo…”
BackgroundFu, Y., Li, J., Cai, W., Huang, Y., Liu, X., Ma, Z., Tang, Z., Bian, X., Zheng, J., Jiang, J., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.018 · Cited by 48
Metadata
- Authors
- Arthur, J. C., & Jobin, C.
- Venue
- Gut Microbes
- Publisher
- Informa UK Limited
- Published
- 2013-05
- Volume
- 4
- Issue
- 3
- Pages
- 253-258
- ISSN
- 1949-0976 (ISSN-L)
- 1949-0984
- OpenAlex
- W2090259800
- Cited by
- 97
- References
- 21
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.